A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD)

Clinical trial NCT04855747 · TERMINATED

Trial details

NCT number: NCT04855747
Sponsor: Levomecor Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Major Depressive Disorder Depression

Start date: 2021-03-30
Primary completion: 2024-12-31
Enrollment: 236

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.